⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Bandhan Value Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | IDFC MF | HDFC MF |
| Category | Equity - Value Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹162.25 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★ | ★★★★★ |
| Benchmark | BSE 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Daylynn Pinto | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -6.34% | 22.64% |
| 3Y | 10.31% | 30.41% |
| 5Y | 11.57% | — |
| Since Inception | 15.56% | 29.15% |
| Risk | ||
| 12.81 | 14.07 | |
| 0.98 | 0.59 | |
| 0.29 | 1.59 | |
| 3.24 | 21.67 | |
| 0.52 | 3.48 | |
| -11.18% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.98% | 1.03% |
| Exit Load | Nil upto 10% of investment and 1% for remaining investment on or before 365D, Nil after 365D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
IDFC MF98%
HDFC MF98%
2.1%Only 2.1% of holdings by weight are common between IDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingIDFC MFHDFC MF
Dr. Reddy's Laboratories Ltd.2.08%3.19%
Category context: Equity vs Equity. Open the full Screener →